- Current Issue
- ACP Hospitalist Weekly
- Supplements
- Blog
- Archives
- Career Connection
- Subscribe to RSS Feeds
Recalls of syringes, AXP bags, generic drugs
From the January ACP Hospitalist, copyright © 2009 by the American College of Physicians
By Jessica Berthold
Recalls and warnings
A recall of ThermoGenesis Corp’s disposable Auto Xpress stem-cell processing bags, lot numbers 08B13 and 08C04. Particulates from the stopcock in the bagset may be released into the sterile, non-pyrogenic fluid path. The introduction of a particulate into the body can cause serious injury to a patient being transfused with cord blood that has been stored in these units, the manufacturer said.
An expanded recall of Ethex Corp. generic drugs that may contain oversized tablets with too much active ingredient. The recall now affects dextroamphetamine sulfate (10 mg); isosorbide mononitrate, extended release (30 mg, 60 mg); morphine sulfate, extended release (15 mg); morphine sulfate, immediate release (15 mg, 30 mg); and propafenone HCl (150 mg, 225 mg, 300 mg). Specific lot information is online.
A recall of one lot of Covidien’s ReliOn hypodermic insulin syringes because of possible mislabeling that may cause patients to get up to 2.5 times the intended dose and lead to hypoglycemia and/or death. The recall applies to lot number 813900 of the product labeled “ReliOn 1cc, 31-gauge, 100 units for use with U-100 insulin.” Some syringes labeled for use with U-40 insulin were mixed with these, packaged together, and sold at Wal-Mart and Sam’s Club stores from Aug. 1 to Oct. 8.
A recall of 1 oz tubes of 10% benzoyl peroxide acne cream marketed as “DG Maximum Strength Acne Medicated Gel,” “Kroger Acne Gel 10% Benzoyl Peroxide Acne Medication” and “Equate: Medicated Acne Gel,” which are sold at Dollar General, Kroger and Wal-Mart, respectively. Some samples of these products contained Burkholderia Cepacia, which can cause infections for people with cuts, scrapes, rashes or other skin conditions; or for those with weakened or suppressed immune systems.
A boxed warning for efalizumab (Raptiva) about the risks of bacterial sepsis, viral meningitis, invasive fungal disease, progressive multifocal leukoencephalopathy and other opportunistic infections. Patients should have received all age-appropriate vaccinations before starting the drug and should be educated about the signs and symptoms of infection, PML (confusion, dizziness or loss of balance, difficulty talking or walking, and vision problems), anemia and thrombocytopenia.
Approvals
Rufinamide (Banzel) as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome. Side effects may include headache, dizziness, fatigue, drowsiness, gait disturbance, double-vision, nausea and vomiting. Patients should be monitored for depression, suicidal thoughts or behavior, and unusual changes in mood or behavior.
Fesoterodine fumarate (Toviaz) for overactive bladder. The 4 mg and 8 mg extended release tablets are available by prescription. Common side effects are dry mouth, constipation, dry eyes and trouble emptying the bladder. The drug isn’t recommended in doses above 4 mg in patients with reduced kidney function, or in patients taking medications like ketoconazole that block the metabolism of the drug. It also shouldn’t be used in patients with severe liver impairment, those who suffer from urinary or gastric retention or those with uncontrolled, narrow-angle glaucoma.
Hospitalist Archives
Quick Links
ACP Hospitalist Weekly
From the July 28, 2010 edition
- After general surgery, sepsis and septic shock far more common than PE, MI
- Opt-out tests in ED detect slightly more patients with HIV
Cartoon Caption Contest
ACP staff has selected three finalists for the latest contest and is now asking readers to vote for their favorite caption to determine the winner.
ACP Career Connection
Looking for a new hospitalist position?
ACP Career Connection can help you find your next job in hospital medicine. Search hospitalist positions nationwide that suit your criteria and preferences. Jobs are posted about two weeks before print publication of Annals of Internal Medicine, ACP Internist, and ACP Hospitalist. Exclusive “Online Direct” opportunities are updated weekly. Check us out online.
Is Your Practice Ready For Meaningful Use?
ACP and AmericanEHR Partners are holding a free Webinar, “Meaningful Use and Its Implications For Your Practice,” featuring Dr. David Blumenthal, National Coordinator for Health Information Technology. Sign up now for this national Webinar on August 4 at 7p.m. ET
MKSAP for Students 4 and Internal Medicine Essentials for Clerkship Students 2 Package
The American College of Physicians introduces the essential book set for medical students. Get both titles for one low price!